NeutriSci International (FRA:1N9) Days Inventory: 866.88 (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NeutriSci International Days Inventory?

NeutriSci International FRA:1N9 Days Inventory is 866.88 as of Sep. 2023.

Days Inventory is also known as Days Sales of Inventory (DSI). NeutriSci International's Average Total Inventories for the three months ended in Sep. 2023 was €0.01 Mil. NeutriSci International's Cost of Goods Sold for the three months ended in Sep. 2023 was €0.00 Mil. Hence, NeutriSci International's Days Inventory for the three months ended in Sep. 2023 was 866.88.

The historical rank and industry rank for NeutriSci International's Days Inventory or its related term are showing as below:

FRA:1N9's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 164.58
* Ranked among companies with meaningful Days Inventory only.

NeutriSci International's Days Inventory declined from Sep. 2022 (1,330.73) to Sep. 2023 (866.88).

Inventory Turnover measures how fast the company turns over its inventory within a year. NeutriSci International's Inventory Turnover for the three months ended in Sep. 2023 was 0.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. NeutriSci International's Inventory-to-Revenue for the three months ended in Sep. 2023 was 4.75.


NeutriSci International  (FRA:1N9) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

NeutriSci International's Inventory Turnover for the three months ended in Sep. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

NeutriSci International's Inventory to Revenue for the three months ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


NeutriSci International Days Inventory Related Terms


NeutriSci International Days Inventory Historical Data

* Premium members only.

The historical data trend for NeutriSci International's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeutriSci International Days Inventory Chart

NeutriSci International Annual Data
Trend Mar13 Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 418.68 889.69 1,438.94 1,328.91 184.60

NeutriSci International Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,330.73 78.44 912.50 912.50 866.88

FRA:1N9 vs ZTS, NBIX: Days Inventory Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NeutriSci International's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeutriSci International Days Inventory vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NeutriSci International's Days Inventory distribution charts can be found below:

* The bar in red indicates where NeutriSci International's Days Inventory falls into.



NeutriSci International Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

NeutriSci International's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

Days Inventory (A: Dec. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2021 ) + Total Inventories (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (0.342 + 0.01) / 2 ) / 0.348*365
=0.176 / 0.348*365
=184.60

NeutriSci International's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:

Days Inventory (Q: Sep. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2023 ) + Total Inventories (Q: Sep. 2023 )) / count ) / Cost of Goods Sold (Q: Sep. 2023 )*Days in Period
=( (0.01 + 0.009) / 2 ) / 0.001*365 / 4
=0.0095 / 0.001*365 / 4
=866.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 866.88 mean?
NeutriSci International (FRA:1N9) has a Days Inventory of 866.88 as of Sep. 2023. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on NeutriSci International and its competitors.
Is NeutriSci International's Days Inventory too high?
NeutriSci International's current Days Inventory is 866.88. The Drug Manufacturers industry median Days Inventory is 164.58. NeutriSci International's value of 866.88 is 426.7% above this industry median.
How does NeutriSci International's Days Inventory compare to ZTS and NBIX?
NeutriSci International's Days Inventory of 866.88 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 164.58. NeutriSci International's value of 866.88 is 426.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.58, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeutriSci International's current Days Inventory of 866.88 is 426.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on NeutriSci International and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeutriSci International's current Days Inventory is 866.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeutriSci International stock overvalued right now?
NeutriSci International (FRA:1N9) has a current Days Inventory of 866.88. The current Days Inventory is 866.88 and 426.7% above the Drug Manufacturers industry median of 164.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For NeutriSci International (FRA:1N9), the current Days Inventory is 866.88 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NeutriSci International Business Description

Address 609 Granville Street, Suite 1600, Vancouver, BC, CAN, V7Y 1C3
NeutriSci International Inc specializes in the production and formulation of nutraceutical products within the B2B industry. By incorporating natural ingredients, it implements industry disrupting patent pending Cryolization Technology to provide B2B partners with the ability to create unparalleled products. Using patent pending proprietary ingredients, technologies, and IP, it can help bring to market effective, solution-oriented products that meet the needs of consumers. The company continues to develop emerging sales channels in the USA, European, Asian & South American markets.